{
  "retracted": false,
  "timestamp": 1410825600000,
  "updates": [
    {
      "timestamp": 1496006320289,
      "identifier": {
        "doi": "10.1212/wnl.0000000000000853"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000000594"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Sustained focal antitumor activity of bevacizumab in recurrent glioblastoma"
}
